Literature DB >> 30422912

Medical Intensive Care Unit Admission Among Patients With and Without HIV, Hepatitis C Virus, and Alcohol-Related Diagnoses in the United States: A National, Retrospective Cohort Study, 1997-2014.

Christopher T Rentsch1,2,3, Janet P Tate2,3, Tessa Steel4, Adeel A Butt5,6,7, Cynthia L Gibert8,9, Laurence Huang10, Margaret Pisani3, Guy W Soo Hoo11,12, Stephen Crystal13, Maria C Rodriguez-Barradas14,15, Sheldon T Brown16,17, Matthew S Freiberg18,19, Christopher J Graber11,12, Joon W Kim20, David Rimland21, Amy C Justice2,3,22, David A Fiellin3,22, Kristina A Crothers4, Kathleen M Akgün3,23.   

Abstract

BACKGROUND: HIV, hepatitis C virus (HCV), and alcohol-related diagnoses (ARD) independently contribute increased risk of all-cause hospitalization. We sought to determine annual medical intensive care unit (MICU) admission rates and relative risk of MICU admission between 1997 and 2014 among people with and without HIV, HCV, and ARD, using data from the largest HIV and HCV care provider in the United States.
SETTING: Veterans Health Administration.
METHODS: Annual MICU admission rates were calculated among 155,550 patients in the Veterans Aging Cohort Study by HIV, HCV, and ARD status. Adjusted rate ratios and 95% confidence intervals (CIs) were estimated with Poisson regression. Significance of trends in age-adjusted admission rates were tested with generalized linear regression. Models were stratified by calendar period to identify shifts in MICU admission risk over time.
RESULTS: Compared to HIV-/HCV-/ARD- patients, relative risk of MICU admission decreased among HIV-mono-infected patients from 61% (95% CI: 1.56 to 1.65) in 1997-2009% to 21% (95% CI: 1.16 to 1.27) in 2010-2014, increased among HCV-mono-infected patients from 22% (95% CI: 1.16 to 1.29) in 1997-2009% to 54% (95% CI: 1.43 to 1.67) in 2010-2014, and remained consistent among patients with ARD only at 46% (95% CI: 1.42 to 1.50). MICU admission rates decreased by 48% among HCV-uninfected patients (P-trend <0.0001) but did not change among HCV+ patients (P-trend = 0.34).
CONCLUSION: HCV infection and ARD remain key contributors to MICU admission risk. The impact of each of these conditions could be mitigated with combination of treatment of HIV, HCV, and interventions targeting unhealthy alcohol use.

Entities:  

Mesh:

Year:  2019        PMID: 30422912      PMCID: PMC6701630          DOI: 10.1097/QAI.0000000000001904

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  25 in total

Review 1.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-12-16

2.  Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients.

Authors:  James M O'Brien; Bo Lu; Naeem A Ali; Greg S Martin; Scott K Aberegg; Clay B Marsh; Stanley Lemeshow; Ivor S Douglas
Journal:  Crit Care Med       Date:  2007-02       Impact factor: 7.598

3.  Comparing alcohol screening measures among HIV-infected and -uninfected men.

Authors:  Kathleen A McGinnis; Amy C Justice; Kevin L Kraemer; Richard Saitz; Kendall J Bryant; David A Fiellin
Journal:  Alcohol Clin Exp Res       Date:  2012-10-10       Impact factor: 3.455

4.  Intensive care unit admitting patterns in the Veterans Affairs health care system.

Authors:  Lena M Chen; Marta Render; Anne Sales; Edward H Kennedy; Wyndy Wiitala; Timothy P Hofer
Journal:  Arch Intern Med       Date:  2012-09-10

5.  Long-term alcohol use patterns and HIV disease severity.

Authors:  Brandon D L Marshall; Janet P Tate; Kathleen A McGinnis; Kendall J Bryant; Robert L Cook; E Jennifer Edelman; Julie R Gaither; Christopher W Kahler; Don Operario; David A Fiellin; Amy C Justice
Journal:  AIDS       Date:  2017-06-01       Impact factor: 4.177

6.  Relative effects of heavy alcohol use and hepatitis C in decompensated chronic liver disease in a hospital inpatient population.

Authors:  Pavan Kumar Mankal; Jean Abed; Jose David Aristy; Khushboo Munot; Upma Suneja; Ellen S Engelson; Donald P Kotler
Journal:  Am J Drug Alcohol Abuse       Date:  2014-10-16       Impact factor: 3.829

7.  Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

Authors:  Gary L Davis; Miriam J Alter; Hashem El-Serag; Thierry Poynard; Linda W Jennings
Journal:  Gastroenterology       Date:  2009-10-25       Impact factor: 22.682

8.  Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.

Authors:  Vincent Lo Re; Michael J Kallan; Janet P Tate; A Russell Localio; Joseph K Lim; Matthew Bidwell Goetz; Marina B Klein; David Rimland; Maria C Rodriguez-Barradas; Adeel A Butt; Cynthia L Gibert; Sheldon T Brown; Lesley Park; Robert Dubrow; K Rajender Reddy; Jay R Kostman; Brian L Strom; Amy C Justice
Journal:  Ann Intern Med       Date:  2014-03-18       Impact factor: 25.391

9.  Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era.

Authors:  Kathleen M Akgün; Janet P Tate; Margaret Pisani; Terri Fried; Adeel A Butt; Cynthia L Gibert; Laurence Huang; Maria C Rodriguez-Barradas; David Rimland; Amy C Justice; Kristina Crothers
Journal:  Crit Care Med       Date:  2013-06       Impact factor: 7.598

10.  A multicentre prospective evaluation of alcohol-related admissions to intensive care units in Wales.

Authors:  Ceri Lynch; Richard Pugh; Ceri Battle
Journal:  J Intensive Care Soc       Date:  2017-03-21
View more
  1 in total

1.  Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.

Authors:  Benjamin J Oldfield; Kathleen A McGinnis; E Jennifer Edelman; Emily C Williams; Adam J Gordon; Kathleen Akgün; Stephen Crystal; Lynn E Fiellin; Julie R Gaither; Joseph L Goulet; P Todd Korthuis; Brandon D L Marshall; Amy C Justice; Kendall Bryant; David A Fiellin; Kevin L Kraemer
Journal:  J Subst Abuse Treat       Date:  2019-11-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.